KFS
BIIB icon

Kaizen Financial Strategies’s Biogen BIIB Stock Holding History

Kaizen Financial Strategies’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$308K Buy
+1,100
New +$297K 0.29% 100

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kaizen Financial Strategies's BIIB Position: Q1 2021 in Review

Kaizen Financial Strategies opened a new position in Biogen (BIIB) in Q1 2021: 1,100 shares worth $308K. The stake represents 0.29% of the portfolio and ranks #100 among its holdings.

1,093 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • Kaizen Financial Strategies held 1,100 shares of Biogen worth $308K as of Q1 2021.
  • Biogen was a new Kaizen Financial Strategies position in Q1 2021.
  • Biogen made up 0.29% of Kaizen Financial Strategies's portfolio in Q1 2021, its #100 holding.
  • 1,093 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on Kaizen Financial Strategies's 13F filing for Q1 2021, filed 28 May 2021.